4.2 Article

Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface

Journal

NEUROMUSCULAR DISORDERS
Volume 24, Issue 2, Pages 143-147

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2013.10.009

Keywords

Acetylcholine receptor; Congenital myasthenic syndrome; Fast channel; Mutation

Funding

  1. Myasthenia Gravis Association/John Moulton Foundation
  2. MRC [G0701521]
  3. Medical Research Council UK [G1002274, 98482]
  4. Medical Research Council [MR/M006824/1, G1002274, G0701521, MR/K000608/1] Funding Source: researchfish
  5. MRC [MR/M006824/1, G1002274, MR/K000608/1] Funding Source: UKRI

Ask authors/readers for more resources

Congenital myasthenic syndromes (CMS) result from the failure to achieve muscle depolarisation due to disorders in the structure and/or function of the neuromuscular synapse. Mutations of the nicotinic acetylcholine receptor (nAChR) form a major subset of CMS. We describe a patient who presented with recurrent apnoeic crises in the neonatal period requiring ventilator support. Electromyography revealed compound muscle action potential decrement upon repetitive stimulation. Sequencing of nAChR subunit genes revealed two missense mutations. One previously reported null mutation p.epsilon Tyr15His, and a second novel missense mutation, p.epsilon Thr38Lys, that is well expressed in mammalian cell culture and thus likely to exert its effect via alteration of ion channel kinetics. Functional analysis revealed abbreviated ion channel bursts characteristic of a fast channel CMS. The mutation p.epsilon Thr38Lys occurs at the interface between the alpha and epsilon subunits of the nAChR pentamer and leads to instability of the open channel. The effects of this mutation on channel function were investigated in relation to other fast channel mutants at an analogous subunit interface within the nAChR pentamer. Fast channel syndromes are frequently characterised by severe myasthenic weakness with apnoeic crises; knowledge of the underlying mutation and its functional consequences can be vital for appropriate therapy and patient management. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available